Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Nexaph.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 103 | 99.39% | Sep 16, 2026 |
| Tirzepatide | 64 | 99.53% | Sep 24, 2026 |
| Tesamorelin | 30 | 97.46% | Sep 16, 2026 |
| BPC-157 | 19 | 99.49% | Sep 24, 2026 |
| Semaglutide | 15 | 98.41% | Mar 6, 2026 |
| Cagrilintide | 13 | 99.14% | Sep 14, 2026 |
| GHK-Cu | 11 | 99.88% | Jun 26, 2026 |
| Ipamorelin | 10 | 99.32% | Jun 6, 2026 |
| CJC-1295 No DAC | 8 | 95.56% | Sep 4, 2026 |
| MOTS-c | 5 | 98.42% | Aug 13, 2026 |
| TB-500 | 4 | 99.53% | Apr 30, 2026 |
| NAD+ | 3 | 98.77% | Jun 1, 2026 |
| PT-141 | 3 | 99.87% | Apr 28, 2026 |
| Sermorelin | 3 | 91.06% | Jan 26, 2026 |
| TB-500 Fragment 17-23 | 2 | 99.12% | Feb 2, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Tirzepatide | NXP-2P2005162026-04 | 99.9% | Lab E | Sep 24, 2026 | verify |
| BPC-157 | BPC1005082026-22 | 99.6% | Lab E | Sep 24, 2026 | verify |
| Tirzepatide | NXP-2P1004162026-03 | 98.25% | Lab N | Sep 20, 2026 | verify |
| BPC-157 | Bpc1005082026-22 | 99.99% | Lab N | Sep 18, 2026 | verify |
| Retatrutide | NXP-3P480102226-0 | 99.9% | Lab G | Sep 16, 2026 | verify |
| Tesamorelin | TES1003212026-20 | 99.8% | Lab G | Sep 16, 2026 | verify |
| Retatrutide | NXP-3P0605132026-02 | 99.8% | Lab E | Sep 15, 2026 | verify |
| Cagrilintide | CAG0505152026-12 | 98% | Lab E | Sep 14, 2026 | verify |
| Tirzepatide | 2TZ3012242025 | 99.9% | Lab E | Sep 10, 2026 | verify |
| Tesamorelin | TES1003212026-20 | 99% | Lab E | Sep 10, 2026 | verify |
| Tirzepatide | NXP-2P1004162026-03 | 99.9% | Lab E | Sep 10, 2026 | verify |
| Retatrutide | NXP-3P1206222026-03 | 99.9% | Lab E | Sep 9, 2026 | verify |
| CJC-1295 No DAC | CJC0505232026-05 | 99.7% | Lab E | Sep 4, 2026 | verify |
| Tirzepatide | NXP-2P1004162026-03 | 98.25% | Lab N | Sep 3, 2026 | verify |
| Tirzepatide | NXP-2P1504032026-04 | 97.24% | Lab K | Aug 27, 2026 | verify |
| Tirzepatide | NXP-2P2005162026-04 | 99.9% | Lab E | Aug 26, 2026 | verify |
| MOTS-c | MOT1007162026-20 | 98.5% | Lab E | Aug 13, 2026 | verify |
| Tirzepatide | NXP-2P1504032026 | 99.8% | Lab G | Aug 9, 2026 | verify |
| Tirzepatide | NXP-2P6003282026-02 | 99.9% | Lab E | Aug 4, 2026 | verify |
| Tirzepatide | NXP-2P3006232026-04 | 99.9% | Lab E | Jul 21, 2026 | verify |
| Retatrutide | NXP-3P1204012026-02 | 99.9% | Lab E | Jul 20, 2026 | verify |
| MOTS-c | MOT1003302026-18 | 98.1% | Lab E | Jul 17, 2026 | verify |
| Retatrutide | NXP-3P1204012026-02 | 98.7% | Lab E | Jul 13, 2026 | verify |
| Retatrutide | NXP-3P2405072026-01 | 99.9% | Lab E | Jul 1, 2026 | verify |
| Tesamorelin | TES1003212026-20 | 98.3% | Lab E | Jul 1, 2026 | verify |
Showing 25 most recent of 293. Search the full database on the CoA page.
Sell or represent Nexaph? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/nexaph/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/nexaph.svg" alt="Nexaph: lab tested, 293 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.